Pfizer Will Ask FDA to Approve Its COVID Vaccine for Kids Under 5
TUESDAY, Feb. 1, 2022 (HealthDay News) — Pfizer Inc. plans to ask the U.S. Food and Drug Administration as soon as Tuesday to authorize its COVID vaccine for emergency use in children aged 6 months to 4 years old. If approved, the two-shot regimen would become the first approved forContinue Reading